By Karlee Weinmann ( October 16, 2014, 8:11 AM EDT) -- U.S. drugmaker AbbVie Inc. pulled the plug Thursday on its record-setting $55 billion plans to merge with British rival Shire PLC in a controversial inversion deal, a stunning reversal it blamed on the U.S. government's push to curb tax-motivated mergers and acquisitions....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.